Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis.
Differential patterns of spinal cord and brain atrophy in NMO and MS.
Multiple sclerosis: from molecules to treatment.
How microglia kill neurons.
Brain-derived neurotrophic factor and its clinical implications.
A novel monoclonal antibody against the C-terminal region of aquaporin-4.
The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis (commentary).
Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.
Myelination: Do Astrocytes Play a Role?
Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
Risk factors for idiopathic optic neuritis recurrence.
Abnormal control of orbicularis oculi reflex excitability in multiple sclerosis.
Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.
Targeting CXCL13 During Neuroinflammation.
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Driving competences and neuropsychological factors associated to driving counseling in multiple sclerosis.
Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect.
Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy.
How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?
Single nucleotide polymorphisms with cis-regulatory effects on long non-coding transcripts in human primary monocytes.
Ten-year follow-up of the 'minimal MRI lesion' subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial.
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.

Pages